| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |